Colgate-Palmolive Q3 earnings boosted after it raises prices again

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Business News News

Business Business Latest News,Business Business Headlines

Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.

Consumer goods giant Colgate-Palmolive Co. CL, -0.45% posted better-than-expected third-quarter earnings early Friday, as it again raised prices by 9.5% globally. The company posted net income of $708 million, or 86 cents a share, for the quarter, up from $618 million, or 74 cents a share, in the year-earlier period. Adjusted per-share earnings also came to 86 cents, ahead of the 80 cent FactSet consensus. Sales rose to $4.915 billion from $4.455 billion a year ago, ahead of the $4.

The company said its base business gross profit margin rose 140 basis points to 58.6%, and was up 190 bps, excluding a negative 50 bps impact from private label sales stemming from the previously disclosed acquisitions of its pet food business. The company said it now expects full-year sales to grow 6% to 8%, compared with prior guidance of 5% to 8%. It expects adjusted EPS growth in the high-single digits, up from prior guidance of the high end of mid-single digits.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Inflation report, energy earnings, Colgate-Palmolive: 3 things to watchInflation report, energy earnings, Colgate-Palmolive: 3 things to watch
Source: Investingcom - 🏆 450. / 53 Read more »

Boston Beer’s stock falls 6% after profit miss as company lowers guidanceCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Source: MarketWatch - 🏆 3. / 97 Read more »

Boston Scientific posts better-than-expected Q3 earningsCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Source: MarketWatch - 🏆 3. / 97 Read more »

Kenvue’s stock slides premarket as company reports slow start to flu and cold seasonCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Source: MarketWatch - 🏆 3. / 97 Read more »